Urogen's Chief Medical Officer Insider Trade: 400K Sale Insights
A high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
Index investing focuses on market-wide exposure with low fees and discipline. This snippet outlines why it appeals to many investors seeking consistency.
20,990 articlesA high-profile insider sale at UroGen Pharma raises questions about market signals and biotech risk. This article unp...
A sharp 178% EPS rise is grabbing attention, paired with an insider stock sale at Rogers Corp. This article breaks do...
Lucid Group sparked a sharp rally after the CEO denied bankruptcy rumors and take-private chatter. This article break...
Investing in eVTOLs isn’t just about flight tech. The real lever could be charging infrastructure. This guide explain...
As Angiodynamics (ANGO) gears up for the 2026 earnings season, investors should focus on orders, backlog, margins, an...
Netflix shares have pulled back from their peak, leaving many investors wondering if the dip represents a buying oppo...
A potential shift toward a friendlier regulatory environment horizon may change the energy investing landscape. This ...
As Xometry heads into 2025 earnings, investors seek clarity on growth, margins, and execution. This guide provides ac...
Lantheus is steering a strategic shift toward PET radiodiagnostics, aiming to unlock new growth. This article breaks ...
Credit investors are increasingly worried about an AI bubble. A Bank of America survey shows the concern rising fast,...
A major gaming operator dominates the spotlight with $11.5 billion in revenue, while a $16 million institutional exit...
Unlock a practical framework for interpreting bridger aerospace (BAER) earnings. This guide breaks down revenue drive...